Pharmacological and biochemical characterization of purified A2a adenosine receptors in human platelet membranes by [3H]‐CGS 21680 binding

@article{Varani1996PharmacologicalAB,
  title={Pharmacological and biochemical characterization of purified A2a adenosine receptors in human platelet membranes by [3H]‐CGS 21680 binding},
  author={Katia Varani and Stefania Gessi and Alessandro Dalpiaz and Pier Andrea Borea},
  journal={British Journal of Pharmacology},
  year={1996},
  volume={117}
}
1 The binding properties of human platelet A2a adenosine receptors, assayed with the A2a‐selective agonist, [3H]‐2‐[p‐(2‐carboxyethyl)‐phenethylamino]‐5′‐N‐ethylcarboxamidoadenosine ([3H]‐CGS 21680), are masked by a non‐receptorial component, the adenotin site. In order to separate A2a receptors from adenotin sites, human platelet membranes were solubilized with 1% 3‐[(3‐cholamidopropyl)dimethylammonio]‐1‐propanesulphonate (CHAPS). The soluble platelet extract was precipitated with polyethylene… 
View on Wiley
europepmc.org
82 Citations
Highly Influential Citations
2
Background Citations
18
Methods Citations
8
Results Citations
2

82 Citations

Citation Type

Citation Type

Characterization of A2A adenosine receptors in human lymphocyte membranes by [3H]‐SCH 58261 binding
TLDR
Thermodynamic data indicate that [3H]‐SCH 58261 binding to human lymphocytes is entropy and enthalpy‐driven, a finding in agreement with the thermodynamic behaviour of antagonists for rat striatal A2A‐adenosine receptors.
[3H]‐SCH 58261 labelling of functional A2A adenosine receptors in human neutrophil membranes
TLDR
Thermodynamic data indicated that [3H]‐SCH 58261 binding to human neutrophils is entropy and enthalpy‐driven, in agreement with the thermodynamic behaviour of antagonists binding to rat striatal A2A adenosine receptors.
Adenosine A2A receptors of human circulating blood elements
TLDR
Thermodynamic data indicated that [3H]SCH 58261 binding to human lymphocytes and neutrophils is entropy and enthalpy driven, a finding in agreement with the thermodynamic behaviour of antagonists binding to rat striatal A2A adenosine receptors.
Caffeine alters A2A adenosine receptors and their function in human platelets.
TLDR
Caffeine intake leads to upregulation of A2A receptors and is accompanied by sensitization to the actions of the agonist HE-NECA, which increased cAMP accumulation and inhibited aggregation of control platelets.
SCH 58261: A selective A2A adenosine receptor antagonists
TLDR
The tritiated form of SCH 58261 specifically labels A2A receptors in discrete regions of the rat brain such as caudate‐putamen, nucleus accumbens, and tuberculum olfactorium.
Interaction of SSR161421, a novel specific adenosine A(3) receptor antagonist with adenosine A(3) receptor agonists both in vitro and in vivo.
Alteration of A3 adenosine receptors in human neutrophils and low frequency electromagnetic fields
Adenosine increases human platelet levels of cGMP through nitric oxide: possible role in its antiaggregating effect.
Cross-talk between adenosine and the oxatriazole derivative GEA 3175 in platelets.
Guanosine exerts antiplatelet and antithrombotic properties through an adenosine-related cAMP-PKA signaling.
...
...

References

SHOWING 1-10 OF 45 REFERENCES
Binding characteristics of the adenosine A2 receptor ligand [3H]CGS 21680 to human platelet membranes.
Pharmacological properties of adenosine receptors and adenosine binding proteins
TLDR
Evidence has been obtained that A1 receptors increase the conductance of receptor‐regulated potassium channels, induce inactivation of calcium channels, and modulate the breakdown of phosphoinositides by phospholipase C.
Partial separation of platelet and placental adenosine receptors from adenosine A2-like binding protein.
TLDR
This method leads to enrichment of adenosine A2 receptors for platelets and adenosines A1 receptors for placenta and provides a useful preparation technique for pharmacologic studies ofadenosine receptors.
[3H]CGS 21680, a selective A2 adenosine receptor agonist directly labels A2 receptors in rat brain.
TLDR
The present results indicate that [3H]CGS 21680 directly labels the high affinity A2 receptor in rat brain without the need to block binding activity at the A1 receptor.
Characterization of the A2 adenosine receptor labeled by [3H]NECA in rat striatal membranes.
TLDR
The regional distribution of [3H]NECA binding and the affinities of adenosine agonists and antagonists for inhibition of binding indicate that the site labeled by [3NECA belongs to the high affinity, or A2a, subclass of A2 receptor.
Binding of the radioligand [3H]‐SCH 58261, a new non‐xanthine A2A adenosine receptor antagonist, to rat striatal membranes
TLDR
The binding to rat striatal A2A adenosine receptors of the new potent and selective antagonist radioligand, [3H]‐5‐amino‐7‐ (2‐phenylethyl)‐2‐(2‐furyl)‐pyrazolo[4,3‐e]‐1,2,4‐triazolo [1,5‐c] pyrimidine, is described.
Thermodynamic analysis of agonist and antagonist binding to membrane-bound and solubilized A1 adenosine receptors.
TLDR
A curvilinear temperature-dependence appears in the agonist binding to slow kinetic component membrane-bound receptors and in the antagonist binding to soluble receptors, but analyzing the semireactions (association-dissociation) involved in each case reveals that the thermodynamic behavior is very different.
Adenosine receptor-induced cyclic AMP generation and inhibition of 5-hydroxytryptamine release in human platelets.
TLDR
It is concluded that an A2a adenosine receptor appears to be involved in the NECA-elicited increases in cyclic AMP levels and inhibition of 5-HT release in human platelets.
A selective binding site for 3H-NECA that is not an adenosine A2 receptor.
8‐(3‐Chlorostyryl)caffeine (CSC) is a selective A2‐adenosine antagonist in vitro and in vivo
...
...